Here, we demonstrated that GCN2 inhibition increased the phosphorylation of AKT in the livers of T2D mice, indicating that GCN2 may also affect glycemia by regulating gluconeogenesis. The gene discussed is AKT1; the disease is type 2 diabetes mellitus.